La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Theratechnologies a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Theratechnologies..

Theratechnologies (NASDAQ:THTX) Azioni, Catena delle Opzioni

Theratechnologies

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Richmond,,Virginia,,Usa,-,9,May,2019:,Illustrative,Editorial,Of

Pre-Market Outlook

AEHR

Penguin Solutions, Inc. - Ordinary Shares

PENG

THTX

La Borsa USA si avvia al ribasso, ma l&#39;attenzione è sui singoli titoli. Tra crolli improvvisi e conti attesi, l&#39;analisi dei nomi più caldi.

Future in rosso a Wall Street: 5 titoli sotto osservazione oggi

Theratechnologies Inc

Earnings

Press Releases

Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements

Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value

News

Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

Soleus Capital Issues Letter to The Board of Theratechnologies

Theratechnologies Provides Update on Sale Process

Health Care

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

Theratechnologies Reports on its Annual Meeting of Shareholders

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

Theratechnologies to Announce Second Quarter 2025 Financial Results

Theratechnologies Reports Financial Results for the Second Quarter 2025

TSX:TH

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Alpha Cognition

Agenus

Anika Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Cabaletta Bio

Compugen

Cardiff Oncology

Citius Oncology

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Forte Biosciences

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Genelux

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lexeo Therapeutics

Seres Therapeutics

MEI Pharma

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nkarta

AVITA Medical

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tenaya Therapeutics

JonesTrading

Cantor Fitzgerald

Canaccord Genuity

Comments

Theratechnologies

Theratechnologies (THTX) Opzioni

Theratechnologies (NASDAQ:THTX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO